01652.HK
Fusen Pharmaceutical Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 1.03
+3.00%Margins
Gross margin
39.8%
EBITDA margin
13.6%
EBIT margin
4.8%
Net margin
-0.8%
FCF margin
13.3%
-0.7%
Return on equity
-0.2%
Return on assets
2.0%
Return on invested capital
0.22x
Asset turnover
HKD 102.8M
Cash from operations
HKD 0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026